ZEB1 and tongue cancer: Our findings strongly suggest that the ZEB1–CA9 axis can be a prognostic biomarker for tongue cancer patients and provides a rationale for the development of anticancer intervention strategies targeting the ZEB1–CA9 axis in clinics.